Inhalation Sciences Sweden AB Stock Börse Stuttgart
Stocks
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Börse Stuttgart
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 28/08 | Inhalation Sciences receives SEK 0.5m from warrants | FW |
| 24/08 | Inhalation Sciences Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 7.17M 747K 643K 605K 552K 1.03M 70.68M 1.04M 2.77M 36.2M 2.81M 2.75M 115M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4.34M 452K 389K 366K 334K 624K 42.76M 626K 1.68M 21.9M 1.7M 1.66M 69.76M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
99.4% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 747K | |
| -1.43% | +0.31% | +23.52% | +16.23% | 227B | |
| -0.42% | -0.28% | +3.89% | -16.91% | 146B | |
| -4.03% | -3.69% | -24.33% | +19.25% | 130B | |
| -4.18% | -3.57% | -57.13% | -13.93% | 69.27B | |
| -3.34% | -3.79% | +8.84% | +17.86% | 51.82B | |
| +0.48% | -1.27% | -18.38% | -13.14% | 49.99B | |
| -2.83% | -2.25% | +14.38% | +28.57% | 42.53B | |
| -1.26% | -0.66% | +30.31% | +52.96% | 40.22B | |
| -2.76% | +2.90% | +117.09% | +34.59% | 32.95B | |
| Average | -2.04% | -0.93% | +10.91% | +13.94% | 87.69B | |
| Weighted average by Cap. | -2.14% | -1.41% | +5.10% | +9.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.15M 991K 932K 851K 1.59M 109M 1.6M 4.27M 55.79M 4.33M 4.23M 178M | 3.04M 317K 273K 256K 234K 438K 29.99M 439K 1.18M 15.36M 1.19M 1.16M 48.92M |
| Net income | -5.15M -537K -462K -434K -396K -741K -50.76M -744K -1.99M -25.99M -2.02M -1.97M -82.79M | -10.16M -1.06M -911K -857K -782K -1.46M -100M -1.47M -3.93M -51.31M -3.98M -3.89M -163M |
| Net Debt | -4M -417K -359K -338K -308K -576K -39.47M -578K -1.55M -20.21M -1.57M -1.53M -64.39M | -2.83M -295K -254K -239K -218K -408K -27.92M -409K -1.09M -14.3M -1.11M -1.08M -45.54M |
Employees
5
Net sales - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
